Upcoming Event: Live Q&A with Long-Term Mesothelioma Survivors on December 10 at 7 p.m. EST. Reserve Your Spot

Malignant Epithelioid Mesothelioma

Fact Checked

Epithelioid mesothelioma is the most common mesothelioma cell type, accounting for 50% to 70% of cases. Symptoms include shortness of breath and weight loss. The median survival rate for epithelioid mesothelioma patients is 18 months. Patients with the epithelial cell type have more aggressive treatment plan options and access to innovative clinical trials.

Patient Advocate Karen Selby explains malignant epithelioid mesothelioma.
Patient Advocate Karen Selby explains malignant epithelioid mesothelioma.
Jump to a Topic:

What Is Epithelioid Mesothelioma?

Epithelial mesothelioma is the most common of the three cell types of mesothelioma cancer. Epithelial and epithelioid are used interchangeably to refer to this asbestos-related cancer.

More than 50% and up to 70% of cases are epithelioid. It has the best prognosis of the three mesothelioma cell types because it responds best to treatment. This means epithelioid cases tend to qualify for the most effective treatment plans.

Patients with this cell type live about six months longer compared to patients with other cell types.

Regarding the types of mesothelioma, location has a greater impact compared to cell type on the kind of treatments a patient will undergo, but cell type has a greater impact on whether a patient can qualify for aggressive treatment.

Characteristics of Epithelioid Cells

Epithelial mesothelioma cells clump together in groups. Each cell is square, cubed, columnar or squamous (flat) in appearance. The nucleus — the area of the cell that contains genetic material — is clearly visible in each cell.

Because epithelioid cells lack mobility and adhere closely together, they are less likely to spread compared to sarcomatoid cells.

This is one of the reasons epithelial mesothelioma has the best prognosis of the different mesothelioma cell types.

Create a Free Personalized Mesothelioma Guide

Were you diagnosed with mesothelioma?

Symptoms of Epithelial Cell Mesothelioma

Symptoms of mesothelioma remain the same regardless of the cells that make up tumors. Epithelioid cells do not cause any unique symptoms, nor does any other cell type.

Initial symptoms of pleural or peritoneal mesothelioma include cough, shortness of breath and lack of appetite. As the disease progresses, more serious symptoms may surface.

Common Mesothelioma Symptoms

  • Shortness of breath

  • Persistent, nonproductive (dry) cough

  • Hoarseness

  • Coughing up blood

  • Low blood oxygen levels and anemia (low iron)

  • Weight loss

  • Feeling full, even without eating

  • Lack of appetite and nausea

  • Fatigue and weakness

Prognosis for Epithelioid Mesothelioma

Median survival of epithelioid patients is 18 months, compared with 10 months for patients with biphasic cell type and seven months for people with sarcomatoid cells, according to data from the National Mesothelioma Virtual Bank published in 2018.

Compared with other cell types, patients with epithelioid cells had an improved prognosis of around 200 additional days of survival. This improved survival rate can amount to years if the cancer is diagnosed and aggressively treated in an early stage.

According to a 2020 study published in Oncology Reports, the prognosis of epithelioid mesothelioma patients is impacted by a protein called connective tissue growth factor. Patients with lower levels of this protein had a better prognosis and longer survival.

Epithelial cell type allows patients to access more aggressive treatment plans and innovative clinical trials, especially when they are being seen at a mesothelioma specialty clinic.

Epithelioid Mesothelioma Cell Subtypes

Epithelioid mesothelioma cells have different subtypes. It can help your doctors tell mesothelioma apart from similar cancers, avoiding misdiagnosis. The cell subtype generally does not affect treatment choices, except for cases of well-differentiated papillary mesothelioma, which is treated like benign mesothelioma.

Tubulopapillary Mesothelioma Cell Sample

Tubulopapillary

This is the most common subtype of epithelioid mesothelioma. Most tubulopapillary mesotheliomas contain well-differentiated cells. It is possible for doctors without mesothelioma experience to mistake this for adenocarcinoma that has spread to the pleura.

Glandular Mesothelioma Cells

Glandular

Tumors with the glandular pattern are mostly composed of gland-like (acinar) structures. This subtype usually develops in the pleural lining. It may be confused with adenocarcinoma that has spread to the pleura.

Adenomatoid Mesothelioma Cell Type

Adenomatoid

Adenomatoid mesothelioma, also known as the microglandular cell type, accounts for 6% of pleural mesothelioma cases. These tumors are made of flat to cube-like cells and are lined by small gland-like structures.

Adenomatoid is sometimes mixed with other kinds of epithelial cells inside a tumor. Doctors may mistake it for benign adenomatoid tumors or metastatic adenocarcinoma of the pleura.

Solid Mesothelioma Cell Variant

Solid

The solid subtype has two patterns: Well-differentiated and poorly differentiated.

Solid, well-differentiated epithelial type is more common. It has round cells in nests, cords or sheets.

The poorly differentiated pattern has relatively unorganized cells that are polygonal (having straight sides) to round in appearance.

A pathologist without expertise in mesothelioma may mistake solid, well-differentiated mesothelioma for benign reactive mesothelial hyperplasia. The poorly differentiated pattern looks like lymphoma and large cell carcinoma.

Deciduoid Mesothelioma Cell Type

Deciduoid

Deciduoid mesothelioma is a rare epithelial subtype that may be caused by factors other than asbestos exposure. This pattern features large round to polygonal cells with sharp borders.

Deciduoid mesothelioma may be mistaken for squamous cell carcinoma, anaplastic large cell lymphoma, gastrointestinal autonomic nerve tumor, pseudotumoral deciduosis, trophoblastic neoplasia and the oxyphilic variant of ovarian clear cell carcinoma.

Well-Differentiated Mesothelioma Cell

Well-Differentiated Papillary Mesothelioma

This cell type grows slow and features small bumps or protrusions lined by a single layer of flat cells.

This very rare mesothelioma cell type usually affects young women and is not related to asbestos exposure. Most cases are considered benign and respond well to surgery.

Epithelial Mesothelioma Diagnosis

Epithelial mesothelioma distribution
Epithelioid mesothelioma accounts for the majority of cases.

Accurately diagnosing epithelioid mesothelioma requires multiple steps. Many patients experience significant delays between onset of symptoms and receiving an accurate diagnosis.

Epithelioid Mesothelioma Diagnostic Challenges

  • Initial symptoms, such as cough and fatigue, mimic less serious respiratory conditions, according to a 2019 Expert Review of Respiratory Medicine article.

  • Primary care doctors want to rule out common causes of symptoms before referring a patient for chest scans.

  • Even after referral for X-rays, CT scans or an MRI, these tests take time to schedule.

  • Imaging only reveals abnormalities; it cannot determine the cause of abnormal chest areas.

  • Even after imaging results are available, it may take time to schedule an appointment for a biopsy.

All these things may get in the way of obtaining a tissue sample. And only a tumor biopsy — often obtained with a fine-needle aspiration, thoracoscopy or video-assisted thoracic surgery — leads to accurate identification of epithelioid mesothelioma.

One of the most important things you can do to minimize diagnostic delays is to share any history of asbestos exposure with your health care provider.

If your doctor knows you’ve been exposed to asbestos, they are more likely to consider a rare cancer such as mesothelioma or another asbestos-related condition.

Role of Immunohistochemistry in Diagnosis

Immunohistochemistry is a laboratory test to detect proteins on the surface of cells. These proteins help classify cancer cell type.

Pathologists use immunohistochemistry to identify epithelioid mesothelioma and differentiate it from another type of cancer called adenocarcinoma.

According to the 2018 ASCO pleural mesothelioma treatment guidelines, immunohistochemistry is recommended to test for suspected mesothelioma tumors.

This analysis will confirm the absence or presence of mesothelioma cell markers, leading to the most accurate diagnosis possible.

Quick Fact:

Your pathology results will show the specific cell type of your cancer. If you haven’t been told your cell type, be sure to ask your doctor and request a copy of the pathology report for your records.

Epithelial Mesothelioma Treatment Options

Patients who seek out specialty mesothelioma care and receive all the treatments for which they are eligible have the best life expectancy. The first step in finding the best mesothelioma treatment is to seek the advice of an expert physician.

Of the three mesothelioma types, epithelial responds best to treatment. Patients diagnosed with it tend to have more treatment and clinical trial options.

Early-stage epithelioid mesothelioma is treated aggressively with a combination of therapies consisting of surgery, chemotherapy and radiation therapy. According to a 2019 report in The Annals of Thoracic Surgery, combination therapy resulted in significantly better outcomes for patients with epithelial malignant pleural mesothelioma.

Late-stage cases respond better to chemotherapy, immunotherapy and Tumor Treating Fields therapy.

Median Survival for Eptihelial Mesothelioma Patients By Treatment Type
Treatment Type Median Survival
No Treatment 10.2 Months
Chemotherapy Alone 15.4 Months
Surgery Plus Chemotherapy 21.1 Months
Multimodal (all three) 21.7 Months

Source: The Annals of Thoracic Surgery, 2019

Common Questions About Epithelial Mesothelioma

How does a mesothelioma cell type affect my prognosis and treatment?

Patients with the epithelioid cell type have the most mesothelioma treatment options because their cell type responds the best to all forms of treatment. Epithelioid patients also live an average of 200 days longer than patients with other cell types.

How do I find a doctor who treats epithelial mesothelioma?

Most oncologists are not trained to treat epithelioid mesothelioma. Mesothelioma doctors have trained for years to specialize in the treatment of this cancer. Our Patient Advocates can help you find a top doctor who treats epithelial mesothelioma.

Get the Compensation You Deserve

File a Claim
Asbestos.com Mesothelioma Packet

Learn About Top Mesothelioma Treatments

Get Your Guide

Immunotherapy & Mesothelioma Clinical Trials

Find Treatment

Registered Nurse and Patient Advocate

Karen Selby joined Asbestos.com in 2009. She is a registered nurse with a background in oncology and thoracic surgery and was the regional director of a tissue bank before becoming a Patient Advocate at The Mesothelioma Center. Karen has assisted surgeons with thoracic surgeries such as lung resections, lung transplants, pneumonectomies, pleurectomies and wedge resections. She is also a member of the Academy of Oncology Nurse & Patient Navigators.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by
Dr. Jacques Fontaine
Medical Review By

7 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Ohara, Y. et al. (2020). Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma.
    Retrieved from: https://pubmed.ncbi.nlm.nih.gov/32705221/
  2. Espinoza-Mercado, F. et al. (2019, April 17). Disparities in Compliance with National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
    Retrieved from: https://doi.org/10.1016/j.athoracsur.2019.03.052
  3. Hiriart E. et al. (2019, April 8). Mesothelium and Malignant Mesothelioma. DOI: 10.3390/jdb7020007
  4. Harris, E.J.A. et al. (2019, January 16). Diagnosis of asbestos-related lung diseases.
    Retrieved from: https://doi.org/10.1080/17476348.2019.1568875
  5. Rossini, M. et al. (2018, April 3). New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
    Retrieved from: https://www.frontiersin.org/articles/10.3389/fonc.2018.00091/full
  6. Kindler, H. et al. (2018, May 1). Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
    Retrieved from: http://ascopubs.org/doi/pdf/10.1200/JCO.2017.76.6394
  7. Wagas, A. et al. (2018). Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198263/
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 15, 2020

Chat live with a patient advocate now